Kimberly Chong

Array ( [id] => 6730733 [patent_doc_number] => 20030186923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Method and reagent for inhibiting P-glycoprotein (mdr-1 gene)' [patent_app_type] => new [patent_app_number] => 10/438683 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8392 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186923.pdf [firstpage_image] =>[orig_patent_app_number] => 10438683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678344 [patent_doc_number] => 20060183700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Cgrp binding nucleic acids' [patent_app_type] => utility [patent_app_number] => 10/513490 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 29740 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183700.pdf [firstpage_image] =>[orig_patent_app_number] => 10513490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7400109 [patent_doc_number] => 20040023390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'SiRNA-mediated gene silencing with viral vectors' [patent_app_type] => new [patent_app_number] => 10/430351 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22161 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023390.pdf [firstpage_image] =>[orig_patent_app_number] => 10430351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297992 [patent_doc_number] => 20040215006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Modulation of tyrosinase expression' [patent_app_type] => new [patent_app_number] => 10/424041 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21238 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20040215006.pdf [firstpage_image] =>[orig_patent_app_number] => 10424041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289525 [patent_doc_number] => 20040110282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost' [patent_app_type] => new [patent_app_number] => 10/409600 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 40459 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110282.pdf [firstpage_image] =>[orig_patent_app_number] => 10409600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678154 [patent_doc_number] => 20030228294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Inhibition of tumor growth via peroxiredoxin 3' [patent_app_type] => new [patent_app_number] => 10/408766 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8057 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228294.pdf [firstpage_image] =>[orig_patent_app_number] => 10408766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470610 [patent_doc_number] => 20040096848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Oligomeric compounds for the modulation HIF-1alpha expression' [patent_app_type] => new [patent_app_number] => 10/407807 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16550 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096848.pdf [firstpage_image] =>[orig_patent_app_number] => 10407807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809050 [patent_doc_number] => 20030198989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Nucleic acid ligands' [patent_app_type] => new [patent_app_number] => 10/408085 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 33911 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20030198989.pdf [firstpage_image] =>[orig_patent_app_number] => 10408085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206762 [patent_doc_number] => 20040087526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Therapeutically useful compositions of DNA-RNA hybrid duplex constructs' [patent_app_type] => new [patent_app_number] => 10/393450 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21419 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087526.pdf [firstpage_image] =>[orig_patent_app_number] => 10393450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251860 [patent_doc_number] => 20050074757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Compositions and methods for inhibiting expression of a mutant gene' [patent_app_type] => utility [patent_app_number] => 10/384463 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10216 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074757.pdf [firstpage_image] =>[orig_patent_app_number] => 10384463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469156 [patent_doc_number] => 20040102408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => new [patent_app_number] => 10/383099 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6131 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102408.pdf [firstpage_image] =>[orig_patent_app_number] => 10383099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675347 [patent_doc_number] => 20040126771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'PRNA chimera' [patent_app_type] => new [patent_app_number] => 10/373612 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14613 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126771.pdf [firstpage_image] =>[orig_patent_app_number] => 10373612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355029 [patent_doc_number] => 20040048816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Restenosis treatment' [patent_app_type] => new [patent_app_number] => 10/239655 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 31909 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10239655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7440396 [patent_doc_number] => 20040185442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Novel polypeptide-human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same' [patent_app_type] => new [patent_app_number] => 10/362240 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12356 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185442.pdf [firstpage_image] =>[orig_patent_app_number] => 10362240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633962 [patent_doc_number] => 20030211516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Compounds and methods for fluorescently labeling nucleic acids' [patent_app_type] => new [patent_app_number] => 10/312264 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14096 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211516.pdf [firstpage_image] =>[orig_patent_app_number] => 10312264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738411 [patent_doc_number] => 20060008801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Molecules associating to c-terminal domain in receptor cell' [patent_app_type] => utility [patent_app_number] => 10/504879 [patent_app_country] => US [patent_app_date] => 2003-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18852 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008801.pdf [firstpage_image] =>[orig_patent_app_number] => 10504879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730725 [patent_doc_number] => 20030186915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Regulatory polynucleotides and uses thereof' [patent_app_type] => new [patent_app_number] => 10/365737 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13073 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186915.pdf [firstpage_image] =>[orig_patent_app_number] => 10365737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145366 [patent_doc_number] => 20050119198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Novel target to inhibit angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/502244 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9157 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119198.pdf [firstpage_image] =>[orig_patent_app_number] => 10502244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852293 [patent_doc_number] => 20030144496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Human RNase H and compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 10/358439 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6022 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144496.pdf [firstpage_image] =>[orig_patent_app_number] => 10358439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395611 [patent_doc_number] => 20040022767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Novel cytokine designated elk ligand' [patent_app_type] => new [patent_app_number] => 10/356289 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15629 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022767.pdf [firstpage_image] =>[orig_patent_app_number] => 10356289 [rel_patent_id] =>[rel_patent_doc_number] =>)